China channel feed

Ge Li melds WuXi VC with Front­line, cre­at­ing an $800M trans-Pa­cif­ic pow­er­house fund now hunt­ing fresh biotech cap­i­tal

8 years ago
Financing

Ge Li’s fast-grow­ing WuXi Bi­o­log­ics sets the stage for a $513M IPO

8 years ago
Financing

Zai Lab CEO Saman­tha Du is rais­ing a $150M biotech fund

8 years ago
Financing

Chi­na has a $1.45B plan to build up its biotech hubs — and of­fi­cials are mov­ing fast

9 years ago

Shang­hai-based EpimAb Bio grows glob­al roots with $25M A round and a key as­sist by Robert Ka­men

9 years ago
Financing

With a big cash as­sist from lo­cal of­fi­cials, BeiGene is build­ing a $330M bi­o­log­ics fa­cil­i­ty in Chi­na

9 years ago
Outsourcing
Pharma

Fi­bro­Gen, As­traZeneca ready Chi­na ap­pli­ca­tion as ane­mia drug scores in two piv­otal stud­ies

9 years ago
R&D
Pharma

In­novent Bi­o­log­ics sets a biotech record in Chi­na with $260M raise for PhI­II work

9 years ago

Chi­na back­ers help bankroll a $100M mega-round as an in­flu­en­tial an­ti­body en­gi­neer read­ies tri­als

9 years ago

Sput­nik 2.0? Chi­nese re­search team first to try CRISPR-Cas9 gene-edit­ing tech on a hu­man

9 years ago

GSK at­tempts to re­make it­self in Chi­na with lo­cal ties

9 years ago
R&D

Chi­nese de­vel­op­ment group blue­prints $1B-plus biotech cam­pus in South San Fran­cis­co

9 years ago
Pharma
First page Previous page 26272829
A service from the Financial Times